{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:11Z","timestamp":1791923591389,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s40261-019-00768-7","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T04:28:20Z","timestamp":1551068900000},"page":"485-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?"],"prefix":"10.1007","volume":"39","author":[{"given":"Leif","family":"Hommers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Reif-Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pfuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Unterecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"768_CR1","doi-asserted-by":"publisher","unstructured":"Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 2018. \n                    https:\/\/doi.org\/10.1111\/bdi.12623\n                    \n                  .","DOI":"10.1111\/bdi.12623"},{"key":"768_CR2","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1007\/s40263-012-0030-1","volume":"27","author":"CM Chang","year":"2013","unstructured":"Chang CM, Sato S, Han C. Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression. CNS Drugs. 2013;27:S21\u20137.","journal-title":"CNS Drugs"},{"issue":"1","key":"768_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40345-017-0080-x","volume":"5","author":"MT Abou-Saleh","year":"2017","unstructured":"Abou-Saleh MT, M\u00fcller-Oerlinghausen B, Coppen AJ. Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression. Int J Bipolar Disord. 2017;5(1):11.","journal-title":"Int J Bipolar Disord"},{"key":"768_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCHEARTFAILURE.112.000178","volume":"6","author":"JC Loh","year":"2013","unstructured":"Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013;6:411\u20139.","journal-title":"Circ Heart Fail"},{"key":"768_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S0140-6736(86)91598-9","volume":"21","author":"P Douste-Blazy","year":"1986","unstructured":"Douste-Blazy P, Rostin M, Livarek B, Tordjman E, Montastruc JL, Galinier F. Angiotensin converting enzyme inhibitors and lithium treatment. Lancet. 1986;21:1448.","journal-title":"Lancet"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9343(88)80054-8","volume":"85","author":"G Simon","year":"1988","unstructured":"Simon G. Combination angiotensin converting enzyme inhibitor\/lithium therapy contraindicated in renal disease. Am J Med. 1988;85:893\u20134.","journal-title":"Am J Med"},{"key":"768_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0033-3182(93)71851-4","volume":"34","author":"M Teitelbaum","year":"1993","unstructured":"Teitelbaum M. A significant increase in lithium levels after concomitant ACE inhibitor administration. Psychosomatics. 1993;34:450\u20133.","journal-title":"Psychosomatics"},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0272-6386(95)90632-0","volume":"25","author":"K Lehmann","year":"1995","unstructured":"Lehmann K, Ritz E. Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. Am J Kidney Dis. 1995;25:82\u20137.","journal-title":"Am J Kidney Dis"},{"key":"768_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0033-3182(98)71345-3","volume":"39","author":"SS Chandragiri","year":"1998","unstructured":"Chandragiri SS, Pasol E, Gallagher RM. Lithium, ACE inhibitors, NSAIDs, and verapamil. Psychosomatics. 1998;39:281\u20132.","journal-title":"Psychosomatics"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1751-7176.2009.00181.x","volume":"11","author":"J Handler","year":"2009","unstructured":"Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J Clin Hypertens (Greenwich). 2009;11:738\u201342.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1532-5415.2004.52221.x","volume":"52","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52:794\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1399-5618.2005.00199.x","volume":"7","author":"I Wilting","year":"2005","unstructured":"Wilting I, Movig KL, Moolenaar M, Hekster YA, Brouwers JR, Heerdink ER, et al. Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disord. 2005;7:274\u201380.","journal-title":"Bipolar Disord"},{"key":"768_CR13","first-page":"398","volume":"53","author":"K DasGupta","year":"1992","unstructured":"DasGupta K, Jefferson JW, Kobak KA, Greist JH. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry. 1992;53:398\u2013400.","journal-title":"J Clin Psychiatry"},{"key":"768_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00004714-199602000-00011","volume":"16","author":"PR Finley","year":"1996","unstructured":"Finley PR, O\u2019Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996;16:68\u201371.","journal-title":"J Clin Psychopharmacol"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/bmj.3.5924.143","volume":"3","author":"V Petersen","year":"1974","unstructured":"Petersen V, Hvidt S, Thomsen K, Schou M. Effect of prolonged thiazide treatment on renal lithium clearance. BMJ. 1974;3:143\u20135.","journal-title":"BMJ"},{"key":"768_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0002-9343(92)90693-6","volume":"93","author":"FJ Correa","year":"1992","unstructured":"Correa FJ, Eiser AR. Angiotensin-converting enzyme inhibitors and lithium toxicity. Am J Med. 1992;93:108\u20139.","journal-title":"Am J Med"},{"key":"768_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004850-200503000-00010","volume":"20","author":"JM Meyer","year":"2005","unstructured":"Meyer JM, Dollarhide A, Tuan IL. Lithium toxicity after switch from fosinopril to lisinopril. Int Clin Psychopharmacol. 2005;20:115\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"768_CR18","first-page":"1053","volume":"129","author":"MP Fischler","year":"1999","unstructured":"Fischler MP, Follath F. Comparative evaluation of ACE inhibitors: which differences are relevant? Schweiz Med Wochenschr. 1999;129:1053\u201360.","journal-title":"Schweiz Med Wochenschr"},{"key":"768_CR19","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1016\/S0195-668X(97)90004-X","volume":"18","author":"JL Reid","year":"1997","unstructured":"Reid JL. From kinetics to dynamics: are there differences between ACE inhibitors? Eur Heart J. 1997;18:E14\u20138.","journal-title":"Eur Heart J"},{"key":"768_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","volume":"97","author":"NJ Brown","year":"1998","unstructured":"Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97:1411\u201320.","journal-title":"Circulation"},{"key":"768_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2125.2000.00103.x","volume":"49","author":"R Greenbaum","year":"2000","unstructured":"Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, O\u2019Grady P, Yee KF, Liao WC, Mangold B. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. Br J Clin Pharmacol. 2000;49:23\u201331.","journal-title":"Br J Clin Pharmacol"},{"key":"768_CR22","first-page":"240","volume":"60","author":"CB Kelly","year":"1991","unstructured":"Kelly CB, Cooper SJ. Toxic elevation of serum lithium concentration by non-steroidal anti-inflammatory drugs. Ulster Med J. 1991;60:240\u20132.","journal-title":"Ulster Med J"},{"key":"768_CR23","doi-asserted-by":"publisher","first-page":"e8525","DOI":"10.1136\/bmj.e8525","volume":"346","author":"F Lapi","year":"2013","unstructured":"Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525\u2013e8525.","journal-title":"BMJ"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40261-017-0598-9","volume":"38","author":"M Sun","year":"2018","unstructured":"Sun M, Herrmann N, Shulman KI. Lithium toxicity in older adults: a systematic review of case reports. Clin Drug Investig. 2018;38:201\u20139.","journal-title":"Clin Drug Investig"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-019-00768-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T19:10:45Z","timestamp":1582571445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-019-00768-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s40261-019-00768-7","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"25 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding has been received for these case reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hommers L, Fischer M, Reif-Leonhard C, Pfuhlmann B and Unterecker S declare that they have no conflict of interest. Deckert J is the co-recipient of a grant of the Bavarian State Government to BioVariance and an investigator of the PREDICT study supported by a EU grant to P1Vital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}